title: Global effects of subchronic treatment of microcystin-LR on rat splenetic protein levels.
abstract: Microcystin-LR (MCLR), released by toxic cyanobacterial blooms, has received worldwide concerns in the past decades for its hepatotoxicity. Recent studies show that microcystins (MCs) can be accumulated in immune organs and exert notable immunotoxicity. In order to better understand cellular responses in immune tissues disrupted by MCLR treatment, this work mainly focuses on the spleen impairments of rats. After a subchronic 50 d exposure (1 or 10 μg/kg body weight per day), spleen index, MCLR accumulation, histological change and plasma lysozyme activity were detected in MCLR-treated rat. Results indicated that prolonged exposure of MCLR led to toxin accumulation and caused severe damage in spleen of rats, and eventually impaired the immune functions. To further our understanding of the toxic effects of MCLR on the spleen and the mechanisms behind it, a proteomic analysis was performed to determine the global effects of MCLR on splenetic protein levels. In total, 48 proteins were identified and showed a significant increase or decrease in abundance compared to the control after MCLR exposure. These proteins are mainly involved in immune response, oxidative stress, energetic metabolism and the cytoskeleton assembly, indicating that MCLR exerts complex toxic effects in rat spleen and jointly results in immunotoxicity.
authors.affiliation: Fisheries College, Huazhong Agricultural University, Wuhan 430070, China.
authors.forename: Guangyu
authors.initials: G
authors.lastname: Li
authors.forename: Wei
authors.initials: W
authors.lastname: Yan
authors.forename: Qin
authors.initials: Q
authors.lastname: Qiao
authors.forename: Jun
authors.initials: J
authors.lastname: Chen
authors.forename: Fei
authors.initials: F
authors.lastname: Cai
authors.forename: Yan
authors.initials: Y
authors.lastname: He
authors.forename: Xuezhen
authors.initials: X
authors.lastname: Zhang
mesh_terms: D000818:Animals; D003599:Cytoskeleton / Q000276:immunology / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects / Q000276:immunology; D004791:Enzyme Inhibitors / Q000009:adverse effects* / Q000494:pharmacology; D008297:Male; D008387:Marine Toxins; D052998:Microcystins / Q000009:adverse effects* / Q000494:pharmacology; D018384:Oxidative Stress / Q000187:drug effects / Q000276:immunology; D020543:Proteome / Q000276:immunology / Q000378:metabolism*; D040901:Proteomics / Q000379:methods; D051381:Rats; D017208:Rats, Wistar; D013154:Spleen / Q000276:immunology / Q000378:metabolism* / Q000473:pathology
chemical_list: D004791:Enzyme Inhibitors; D008387:Marine Toxins; D052998:Microcystins; D020543:Proteome; C057862:cyanoginosin LR